As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let's look at two noteworthy recent insider buys.
At Xeris Pharmaceuticals (NASDAQ:XERS), a filing with the SEC revealed that on Monday, See Remarks Paul R. Edick bought 30,000 shares of XERS, at a cost of $9.12 each, for a total investment of $273,585. So far Edick is in the green, up about 6.6% on their buy based on today's trading high of $9.72. Xeris Pharmaceuticals is trading up about 4.8% on the day Wednesday. This buy marks the first one filed by Edick in the past twelve months.
And also on Monday, EVP, Clinical Strategies Kelli Mari Howell purchased $258,930 worth of Alphatec Holdings (NASDAQ:ATEC), purchasing 100,000 shares at a cost of $2.59 a piece. This purchase marks the first one filed by Howell in the past twelve months. Alphatec Holdings is trading up about 7.1% on the day Wednesday. So far Howell is in the green, up about 5.8% on their purchase based on today's trading high of $2.74.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.